Global research firm ranked Cylera as a leader in the Connected Medical Devices report, recognizing their healthcare IoT asset intelligence and cybersecurity platform. Read more on Cylera →
TETmedical appointed diagnostics commercialization executive Arjun Ishwar as chief commercial officer as NSE-FAST advances toward pivotal study.
A peer-reviewed preclinical study found AVA-003 outperformed chlorhexidine against Candida auris on skin, advancing AvantGuard’s development program.
